SLC26A6 and type 2 diabetes mellitus: In a previous study, we found the expression and activity of Slc26a6 were more increased in the cardiac tissues of db/db mice (a type 2 diabetes mellitus mouse model) than in normal cardiac tissues and that Slc26a6 enhancement induced an exacerbated intracellular acidification after a cardioplegia-induced arrest [5].